- C80.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C80.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C80.1 – other international versions of ICD-10 C80.1 may differ.
ICD-10-CM C80.1 is grouped within Diagnostic Related Group(s):
- 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o. R. Procedures with mcc
- 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o. R. Procedures with cc
- 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o. R. Procedures without cc/mcc
- 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
- 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
- 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
- 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
- 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc
Applicable To
- Cancer NOS
- Cancer unspecified site (primary)
- Carcinoma unspecified site (primary)
- Malignancy unspecified site (primary)
Type 1 Excludes
- secondary malignant neoplasm of unspecified site (C79.9)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to C80.1:
- unspecified site (primary) > Cancer
- unspecified site (primary) > Carcinoma (malignant)
- unspecified site (primary) > Malignancy
- unspecified site > Sarcomatosis
- malignant > Tumor
- fusiform cell (type) > malignant C80.1
- giant cell (type) > malignant C80.1
- mixed NEC > malignant C80.1
- small cell (type) > malignant C80.1
- spindle cell (type) > malignant C80.1
- unclassified > malignant C80.1